Jordan Greco is an accomplished, creative, and collaborative scientist and entrepreneur who has devoted his career to translating innovative research into viable commercial products with therapeutic benefit. Highlights of his professional career include: • the execution of preclinical studies and establishment of manufacturing paradigms for the commercialization of a novel protein-based artificial retina to treat advanced retinal degeneration;• a diverse academic record that fostered interdisciplinary collaboration, a comprehensive teaching experience, and leadership training;• a strong background in scientific communication, including the successful submission of various government grant proposals (>$10M in secured funding), publications (>20 articles), one patent (PCT/US18/31469), and several abstracts for invited speakerships;• the coordination of a diverse team of researchers, advisors, consultants, and contractors to develop the preclinical strategy around a unique drug/device combination product for the treatment of blinding retinal degenerative diseases;• the design and development of novel biophotonic devices, including protein-based retinal implants, photovoltaic solar cells, holographic associative processors, and three-dimensional optical memories; • the development of a novel series of experiments to investigate layer-by-layer manufacturing on the International Space Station;• the integration of experiments and theoretical simulations to investigate the excited state properties of linear polyenes, biological chromophores, and retinylidene proteins.